Zobrazeno 1 - 10
of 162
pro vyhledávání: '"E L Luchikhina"'
Autor:
I A Guseva, A V Smirnov, N V Demidova, M Yu Krylov, A S Avdeeva, E Yu Samarkina, E L Luchikhina, D E Karateev, D D Abramov, E L Nasonov
Publikováno v:
Терапевтический архив, Vol 90, Iss 5, Pp 38-43 (2018)
Objective. To clarify the association between HLA-DRB1 and TNFα (-308G>A) genes polymorphism and joint destruction/further progression during 12 months of the follow-up period (FUP) in patients with early (
Externí odkaz:
https://doaj.org/article/485938261a6c458aa6c7809045487b63
Autor:
I G Kirillova, D S Novikova, T V Popkova, E N Aleksandrova, A A Novikov, Yu N Gorbunova, E I Markelova, Yu O Korsakova, S I Glukhova, A V Volkov, E L Luchikhina, N V Demidova, K A Kasumova, S A Vladimirov, M A Kanonirova, G L Lukina, D E Karateev, E L Nasonov
Publikováno v:
Терапевтический архив, Vol 88, Iss 5, Pp 19-26 (2016)
Aim. To determine N-terminal pro-brain natriuretic peptide (NT-proBNP) levels in patients with early rheumatoid arthritis (RA) before the use of disease-modifying antirheumatic drugs (DMARDs); to compare NT-proBNP values with traditional risk factors
Externí odkaz:
https://doaj.org/article/f7c1e68a78364be78a49b432ab41d573
Autor:
I G Kirillova, D S Novikova, T V Popkova, Yu N Gorbunova, E I Markelova, Yu O Korsakova, A V Volkov, E N Alexandrova, A A Novikov, O A Fomicheva, E L Luchikhina, D E Karateev, E L Nasonov
Publikováno v:
Терапевтический архив, Vol 87, Iss 5, Pp 16-23 (2015)
Aim. To estimate the rate of diastolic dysfunction (DD) of the left and right ventricles (LV and RV) in patients with early rheumatoid arthritis (RA) before using disease-modifying antirheumatic drugs (DMARDs) therapy and to investigate its associati
Externí odkaz:
https://doaj.org/article/a465ab4e407f4422bf4328f84cfa59d5
Autor:
Tatiana Viktorovna Korotaeva, E Yu Loginova, E L Luchikhina, O V Pushkova, E M Akhmetova, A A Glazkov, A V Volkov, D E Karateev, E L Nasonov
Publikováno v:
Научно-практическая ревматология, Vol 51, Iss 5, Pp 495-499 (2013)
The diagnosis of enthesitis can help in differentiating early psoriatic arthritis (ePsA) from early rheumatoid arthritis (eRA).Objective. To estimate the diagnostic value of detecting enthesitis during clinical examination and ultrasound in ePsA and
Externí odkaz:
https://doaj.org/article/ea415fd5e6224ba2914a6828b853d8c0
Association of genetic markers with the efficiency of tocilizumab treatment for rheumatoid arthritis
Autor:
Irina Anatolyevna Guseva, E Yu Panasyuk, N E Soroka, A S Avdeeva, E N Aleksandrova, E L Luchikhina, E E Gubar, E V Fedorenko, T N Gavva, E S Tsvetkova, E Yu Loginova, E Yu Samarkina, G V Lukina, D Yu Trofimov, E L Nasonov
Publikováno v:
Научно-практическая ревматология, Vol 51, Iss 4, Pp 377-382 (2013)
Objective: to study the association of polymorphic variants of the genes playing a pivotal role in the processes of inflammation with the efficiency of tocilizumab (TCZ) therapy in patients with active rheumatoid arthritis (RA). Subjects and methods.
Externí odkaz:
https://doaj.org/article/04b1f496599e4e32a3b6d0bdb5ac4476
Autor:
Dmitri Evgenyevich Karateev, E N Aleksandrova, E L Luchikhina, A A Novikov, V I Mazurov, I G Salikhov, E I Shmidt, N A Shostak, E L Nasonov
Publikováno v:
Современная ревматология, Vol 7, Iss 2, Pp 40-45 (2013)
Externí odkaz:
https://doaj.org/article/1930070e463040979f1d12a3cfdd715d
Autor:
E Yu Panasyuk, V N Amirdzhanova, Anastasia Sergeyevna Avdeyeva, E L Luchikhina, E N Aleksandrova, A A Novikov, E L Nasonov
Publikováno v:
Научно-практическая ревматология, Vol 51, Iss 2, Pp 104-110 (2013)
Objective: to estimate quality of life changes in patients with rheumatoid arthritis (RA) while adding tocilizumab (TCZ) to therapy with disease-modifying antirheumatic drugs (DMARDs) and to study the efficiency and safety of the therapy in RA patien
Externí odkaz:
https://doaj.org/article/1c1ebb9d2e8340afab1e628e634829b7
Autor:
Aleksandr Aleksandrovich Novikov, E N Aleksandrova, A N Gerasimov, M V Cherkasova, D E Karateev, E L Luchikhina, E L Nasonov
Publikováno v:
Научно-практическая ревматология, Vol 51, Iss 2, Pp 111-116 (2013)
Subjects and methods. 102 patients with early RA (79 women and 23 men; median age 51 years [41 to 62, 25th to 75th percentile]; disease duration 4 months [2.5 to 6.0]; DAS28 5.4 [4.1 to 5.9]) were examined. A comparison group consisted of 616 patient
Externí odkaz:
https://doaj.org/article/71fac59df72b499d88746d4e10be63ba
Autor:
Dmitri Evgenyevich Karateev, E L Luchikhina, Yu V Muravyev, N V Demidova, G I Grineva, D S Novikova, E N Aleksandrova, A A Novikov, A V Smirnov, A V Volkov, A S Avdeyeva, E V Lopareva, Yu A Olyunin, G V Lukina, T V Popkova, E L Nasonov
Publikováno v:
Научно-практическая ревматология, Vol 51, Iss 2, Pp 117-125 (2013)
The international recommendations «Treat to target» (T2T) underline the greatest importance of treatment strategy for the success of treating rheumatoid arthritis (RA). Evaluation of the efficiency of this approach obviously requires special strate
Externí odkaz:
https://doaj.org/article/689efa77aeab4a5dad6e6090ff4901dd
Autor:
D E Karateev, E L Nasonov, E L Luchikhina, V I Mazurov, I G Salikhov, E I Shmidt, N A Shostak
Publikováno v:
Терапевтический архив, Vol 84, Iss 8, Pp 22-28 (2012)
Aim. To confirm the efficacy and safety of adalimumab (ADA) added to the standard antirheumatic therapy performed in patients with rheumatoid arthritis (RA) of moderate and high activities.Subjects and methods. The open-labeled multicenter study enro
Externí odkaz:
https://doaj.org/article/31de772a01ed48b384f25eff03258d48